For sales

📢Highlights from the Week of 02 Dec 2025 – 08 Dec 2025, 2025 in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of 02 Dec 2025 – 08 Dec 2025 accord ( EU , Launch ) Accord Healthcare launches its denosumab biosimilars, OSVYRTI and JUBEREQ, in Europe for bone health conditions like osteoporosis FRESENIUS KABI ( FDA, Approval ) Fresenius Kabi's partner, SamChunDang Pharm, receives FDA acceptance to review its proposed aflibercept biosimilar for ophthalmic disorders SAMSUNG BIOEPIS ( EMA, Approval ) Samsung Bioepis' pre-filled syringe presentation of its Lucentis biosimilar, BYOOVIZ, receives European approval Hope Medicine ( FDA, Fast Track ) Hope Medicine's HMI-115 gains FDA Fast Track status, accelerating global development for endometriosis pain All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.